FAABORG PHARMA A/S — Credit Rating and Financial Key Figures

FAABORG PHARMA A/S (CVR number: 26190770) is a company from FAABORG-MIDTFYN. The company recorded a gross profit of 10.6 mDKK in 2023. The operating profit was 2332 kDKK, while net earnings were 1610.6 kDKK. The profitability of the company measured by Return on Assets (ROA) was 12.9 %, which can be considered good but Return on Equity (ROE) was 22.4 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 65 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. FAABORG PHARMA A/S's liquidity measured by quick ratio was 2.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.